Oculoplastics News

KOLOA, Hawaii — At Hawaiian Eye 2020, Wendy W. Lee, MD, professor of clinical ophthalmology and director of Bascom Palmer Aesthetic Center at the Bascom Palmer Eye Institute, discusses safety and injection technique pearls from the Live Injection Workshop.

KOLOA, Hawaii — Skin care accounts for a significant portion of the $400 billion global beauty and personal care industry, and ophthalmologists have a unique opportunity to intersect with those markets, according to a presenter.

KOLOA, Hawaii — Interpersonal relationship skills can be an overlooked quality that oculoplastic surgeons would do well to develop, Eli L. Chang, MD, FACS, told fellow panelists at Hawaiian Eye 2020.

KOLOA, Hawaii — Patients with thyroid eye disease treated with teprotumumab demonstrated a significant reduction in proptosis compared with those treated with placebo, according to phase 3 results from the OPTIC trial.

An 83-year-old woman with diet-controlled type 2 diabetes presented to Lahey Medical Center as a transfer from Bermuda for presumed orbital cellulitis.

In children with congenital nasolacrimal canal dysplasia, the combination of endoscopic dacryocystorhinostomy and lacrimal CT scan may be advantageous over traditional solutions, according to retrospective study.

The Dermatologic and Ophthalmic Drugs Advisory Committee of the FDA voted 12-0 Friday in favor of recommending approval of a biologics license application for teprotumumab, an experimental human monoclonal antibody shown to dramatically reduce the most debilitating symptoms of Graves’ orbitopathy.

SAN FRANCISCO — A bilayer dermal regeneration matrix template improved lower eyelid retraction in patients undergoing repair, Cat Burkat, MD, said in a presentation at the American Society of Ophthalmic Plastic and Reconstructive Surgery meeting.

SAN FRANCISCO — Injections of 5-fluorouracil in patients with conjunctival cicatrix secondary to Stevens-Johnson syndrome or ocular cicatricial pemphigoid contributed to improved clinical outcomes and fewer mucous membrane graft procedures, Nina Jovanovic, MD, MPH, reported at the American Society of Ophthalmic Plastic and Reconstructive Surgery meeting.

SAN FRANCISCO — Rather than thinking of ophthalmic Graves’ disease as one entity classified as “mild” or “moderate to severe,” William R. Nunery, MD, FACS, told colleagues at the American Society of Ophthalmic Plastic and Reconstructive Surgery meeting that thyroid eye disease should be considered as two separate subtypes.